Related Experiment Video
Updated: Jun 22, 2026

Fluorimetric Techniques for the Assessment of Sperm Membranes
Published on: November 28, 2018
Dual-Parameter Hypoxia Sensing in Spermatozoa: A Transformative Nitroreductase/Viscosity Fluorescent Probe Unravels
Lin Lei1, Kun Li1, Yi-Fei Tang2
1Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China.
Abstract:
Sperm energy metabolism, including oxidative phosphorylation and glycolysis, is critical for sperm function. Environmental stressors like hypoxia can disrupt metabolic activities, potentially leading to fertilization failure. As an NADH-dependent flavin reductase, altered nitroreductase (NTR) levels may reflect hypoxic metabolic abnormalities. However, no studies have reported the detection of hypoxia conditions in spermatozoa to date. To address this diagnostic gap, we first performed metabolomic analysis on normal and clinically infertile spermatozoa. Hypoxia-mediated metabolic dysregulation in spermatozoa is unveiled as a pivotal mechanism underlying idiopathic male infertility, with clinical metabolomics revealing impaired anaerobic glycolysis (50% lactate reduction, p < 0.0001; 1174-fold PEP accumulation, p < 0.0001 vs controls). Subsequently, to address the critical need for monitoring the hypoxia microenvironment of spermatozoa, we developed PPy, a dual-response fluorescent probe with NTR and viscosity. This first-in-spermatozoa probe demonstrates viscosity-driven near-infrared enhancement at 706 nm (32-fold, Stokes shift >220 nm) and NTR-activated green emission around 562 nm, enabling real-time hypoxia mapping in live systems. Confocal validation in pathological models (H2O2-stressed/infertile spermatozoa) quantified obvious NTR activity loss and diminished capacity for viscosity regulation and successfully established NTR as a diagnostic biomarker (AUC = 0.975, ΔMFI < 12.39% with 100% sensitivity and 90% specificity). Thus, our study introduces innovative tools and actionable biomarkers for clinical andrology settings, which uncover profound hypoxia-induced impairments in spermatozoa of infertile patients, thereby advancing both therapeutic strategies for infertility and mechanistic investigations into fertilization disorders.
More Related Videos
08:22Using an Extracellular Flux Analyzer to Measure Changes in Glycolysis and Oxidative Phosphorylation during Mouse Sperm Capacitation
Published on: January 22, 2020
08:32Author Spotlight: Advancing Male Infertility Research by Unraveling Sperm Metabolism and Mitochondrial Function
Published on: June 23, 2023